Renal Denervation in Patients With Refractory Hypertension

Completed · Not applicable

Conditions studied: Hypertension

In brief

The purpose of this study is to investigate the clinical utility of renal denervation for the treatment of refractory hypertension.

Key facts

Study ID

NCT00753285

Run by

Medtronic Vascular

People needed

35

Starts

2008-09-01

Expected to finish

2013-05-01

Last updated by the study team

2014-11-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Systolic blood pressure of 160 mmHg or greater
• On 3 or more antihypertensive medications
• eGFR >= 45 mL/min

You may not qualify if…

• Renal artery abnormalities
• Known secondary hypertension attributable to a cause other than sleep apnea
• MI, angina, CVA within 6 months
• Type 1 diabetes
• Others

Where it is running

• Prairie Heart Institute — Springfield, Illinois, United States
• Hennepin County Medical Center — Minneapolis, Minnesota, United States
• MetroHealth Medical Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.